Search research articles
Contact Us
Filters
Showing results (651-660 of 847) with videos related to
Page
of 85
Sort By:
Science Translational Medicine
|
April 3, 2024
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
Ziyan Pan, Rasha El Sharkway, Ali Bayoumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2024
The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosis
Eric Kalo, Lukas Sturm, Michael Schultheiss, et al.
Nature Communications
|
May 5, 2026
Charting spatial ligand-target activity using Renoir
Narein Rao, Tanush Kumar, Dina Kazemi, et al.
The Journal of the Association of Physicians of India
|
March 12, 2026
Mineralocorticoid Receptor Antagonist and Its Combinations in Heart Failure
Kiron Varghese, Jacob George, Rajeev Khanna, et al.
Plos One
|
November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study
Rachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 12, 2020
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.
Journal of Gastroenterology and Hepatology
|
January 15, 2015
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection
Matthew T Kitson, Jacob George, Gregory J Dore, et al.
Pharmacological Research
|
March 28, 2015
Effect of resveratrol on experimental non-alcoholic steatohepatitis
Sara Heebøll, Karen Louise Thomsen, Andrew Clouston, et al.
Diabetes Research and Clinical Practice
|
August 11, 2023
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study
Matina Kouvari, Sophia C Mylonakis, Angeliki Katsarou, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
Jason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Page
of 85
Search research articles
Search
Showing results (651-660 of 847) with videos related to
Sort By:
Page
of 85
Science Translational Medicine
|
April 3, 2024
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
Ziyan Pan, Rasha El Sharkway, Ali Bayoumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2024
The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosis
Eric Kalo, Lukas Sturm, Michael Schultheiss, et al.
Nature Communications
|
May 5, 2026
Charting spatial ligand-target activity using Renoir
Narein Rao, Tanush Kumar, Dina Kazemi, et al.
The Journal of the Association of Physicians of India
|
March 12, 2026
Mineralocorticoid Receptor Antagonist and Its Combinations in Heart Failure
Kiron Varghese, Jacob George, Rajeev Khanna, et al.
Plos One
|
November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study
Rachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 12, 2020
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.
Journal of Gastroenterology and Hepatology
|
January 15, 2015
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection
Matthew T Kitson, Jacob George, Gregory J Dore, et al.
Pharmacological Research
|
March 28, 2015
Effect of resveratrol on experimental non-alcoholic steatohepatitis
Sara Heebøll, Karen Louise Thomsen, Andrew Clouston, et al.
Diabetes Research and Clinical Practice
|
August 11, 2023
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study
Matina Kouvari, Sophia C Mylonakis, Angeliki Katsarou, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2010
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
Jason Grebely, Kathy Petoumenos, Margaret Hellard, et al.
Page
of 85